Sofinnova Partners Announces Two First Investments from its MD Start III Medtech Acceleration Fund
Summary
The most recent investment is in MastOR, a French company leveraging its core expertise in surgical robotics to develop enhanced laparoscopic devices to improve the precision and ergonomics of minimally-invasive surgery. The company was founded in 2019 by a renowned pioneer in laparoscopic surgery, Professor Brice Gayet of the Paris-based Institut Mutualiste Montsouris, and entrepreneur, Pierre Campredon. “Our network and partnerships have yielded a rich deal flow pipeline and we are confident in the potential for this fund to continue uncovering first-class devices that address major unmet medical needs.” Sofinnova Partners is a leading European venture capital firm specialized in Life Sciences. For more information, please visit: www.sofinnovapartners.com MastOR SAS is a Paris-based, early stage medical device company, developing a surgical robot for laparoscopy assistance. The core technology is derived from joint research between the ISIR robotics lab at Sorbonne University and Professor Brice Gayet, a world-renowned surgeon and pioneer in minimally-invasive surgery.